- 99Reports naming them
- 2Categories
- 33Regions & countries
- See reportsGrowth in full reports
Where they show up
Geographies
- Africa 3
- APAC 3
Australia 3
Brazil 3
Canada 3
China 3
Ecuador 3
Egypt 3- Europe 3
France 3
Germany 3- Global 3
Hong Kong 3
India 3
Italy 3
Japan 3
Kenya 3- Latin America 3
Malaysia 3
Mexico 3- Middle East 3
New Zealand 3- North America 3
Philippines 3
Russia 3
Saudi Arabia 3
Singapore 3
South Africa 3
Spain 3
Thailand 3
UAE 3
UK 3
US 3
Samsung Biologics's markets
| Market | Category | World size | Growth |
|---|---|---|---|
| Biologics CDMO | Healthcare Services | In full report | In full report |
| Biosimilar Development Services | Healthcare Services | In full report | In full report |
| Cell and Gene Therapy CDMO | Pharmaceuticals | In full report | In full report |
Companies they compete with most
Named as key players in the same markets as Samsung Biologics (number of shared markets).
AGC Biologics2 shared markets
Catalent2 shared markets
Lonza Ltd2 shared markets
WuXi Biologics2 shared markets
Celltrion1 shared market
Charles River Laboratories1 shared market
FUJIFILM Holdings Corporation1 shared market
Intas Pharmaceuticals1 shared market
Catalent2 shared markets
Lonza Ltd2 shared markets
WuXi Biologics2 shared markets
Celltrion1 shared market
Charles River Laboratories1 shared market
FUJIFILM Holdings Corporation1 shared market
Intas Pharmaceuticals1 shared market
Recent reports naming Samsung Biologics
- Pharmaceuticals South Africa Cell and Gene Therapy CDMO Market Analysis
- Pharmaceuticals US Cell and Gene Therapy CDMO Market Analysis
- Pharmaceuticals Thailand Cell and Gene Therapy CDMO Market Analysis
- Pharmaceuticals Singapore Cell and Gene Therapy CDMO Market Analysis
- Pharmaceuticals Saudi Arabia Cell and Gene Therapy CDMO Market Analysis
- Pharmaceuticals Russia Cell and Gene Therapy CDMO Market Analysis
- Pharmaceuticals Philippines Cell and Gene Therapy CDMO Market Analysis
- Pharmaceuticals New Zealand Cell and Gene Therapy CDMO Market Analysis